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Abstract: The human genome must be tightly packaged in order to fit inside the nucleus of a cell. Genome organization is 
functional rather than random, which allows for the proper execution of gene expression programs and other biological 
processes. Recently, three-dimensional chromatin organization has emerged as an important transcriptional control 
mechanism. For example, enhancers were shown to regulate target genes by physically interacting with them regardless of 
their linear distance and even if located on different chromosomes. These chromatin contacts can be measured with the 
“chromosome conformation capture” (3C) technology and other 3C-related techniques. Given the recent innovation of 
3C-derived approaches, it is not surprising that we still know very little about the structure of our genome at high-
resolution. Even less well understood is whether there exist distinct types of chromatin contacts and importantly, what 
regulates them. A new form of regulation involving the expression of long non-coding RNAs (lncRNAs) was recently 
identified. lncRNAs are a very abundant class of non-coding RNAs that are often expressed in a tissue-specific manner. 
Although their different subcellular localizations point to their involvement in numerous cellular processes, it is clear that 
lncRNAs play an important role in regulating gene expression. How they control transcription however is mostly 
unknown. In this review, we provide an overview of known lncRNA transcription regulation activities. We also discuss 
potential mechanisms by which ncRNAs might exert three-dimensional transcriptional control and what recent studies 
have revealed about their role in shaping our genome. 
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INTRODUCTION 
  Organisms with large genomes face the interesting 
problem of having to contain their genetic material within 
very small cellular volumes. For example, a human diploid 
genome measures approximately 2 meters in length and must 
fit within a micron-sized nucleus. Our genomic DNA must 
consequently be extensively packaged in a functional manner 
that allows activities like transcription, DNA replication and 
repair to occur properly. Although exactly how our genome 
is functionally organized in vivo is poorly understood, 
several key features appear common to most cell types (Fig. 
(1)). First, chromosomes are known to occupy distinct 
nuclear areas that are termed “chromosome territories” (CT). 
Gene-rich chromosomes tend to localize to the center of the 
nucleus and gene-poor near the periphery (reviewed in [1]). 
Genomic domains with similar activities and co-regulated 
genes often co-localize in vivo (reviewed in [2]). Moreover, 
genes located near anchor points where interphase 
chromosomes attach to the nuclear matrix tend to be poorly 
transcribed (reviewed in [3]). Together, these observations 
clearly reveal the existence of an intimate relationship 
between the organization of our genome in the nuclear space 
and gene activity.  
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  At the molecular level, spatial genome organization can 
critically affect gene expression. In vivo, genomic DNA 
exists in the form of chromatin where DNA is associated 
with histone and non-histone proteins. While it is well 
known that chromatin composition can directly shape gene 
activity [4, 5], three-dimensional chromatin organization is 
also emerging as an important gene regulation mechanism. 
For example, it was shown that distal control DNA elements 
could regulate target genes located on the same or on 
different chromosomes by physically interacting with them 
[6, 7]. This type of long-range regulation has been reported 
for genes located throughout the genome that are involved in 
various cellular pathways [8-12]. Consequently, the genome 
is now viewed as a functional network of physical contacts 
within (cis) and between (trans) chromosomes. These 
physical DNA contacts can be mapped at high-resolution 
with technologies such as the “chromosome conformation 
capture” (3C) and other 3C-related methods including 3C-
Carbon Copy (5C) and Hi-C [13-17]. Given the recent 
innovation and sophistication of these approaches, it is not 
surprising that we still know very little about genome 
organization at the molecular level. In fact, most questions 
remain unanswered: How many types of contacts exist? 
What are their relative contributions to overall genome 
organization and to various genome functions? What are 
their tissue-specificities? What are their roles in the 
establishment and/or maintenance of cellular identity? What 
is their involvement in human disease? Answers to these 
questions will require extensive mapping and classification 308 Current Genomics, 2011, Vol. 12, No. 5 Wang et al.
of chromatin interactions genome-wide under various 
cellular conditions. Only then will we be able to distinguish 
between regulated and structural contacts, and understand 
the outcome of altering either type on cellular function. 
  Even less well understood is what mediates chromatin 
interactions and how they are regulated. It was shown that 
chromatin contacts could be mediated by tissue-specific 
transcription factors. Such is the case for the beta-globin 
cluster where DNA looping between the locus control region 
(LCR) and activated beta-globin genes was shown to require 
the GATA-1 transcription factor and co-factor FOG-1 [18]. 
This type of long-range control mechanism where enhancers 
and distal promoters are brought in close physical proximity 
to each other by transcription factors has been found at other 
loci. These include many estrogen-regulated genes [19], the 
B lymphocyte-specific induction of CIITA by PU.1 [20], and 
MYC activation by TCF and the beta-catenin co-activator 
complex [21].  
  Other chromatin-binding proteins such as the CCCTC-
binding factor (CTCF) and cohesin also appear to play 
critical roles in genome organization and gene expression 
[22, 23]. Mammalian CTCF is a DNA-binding protein 
associated with insulator sequences, boundary elements and 
imprinting control regions, all of which are thought to 
organize our genome into functional subdomains. CTCF is 
known to form networks of chromatin loops genome-wide 
and is viewed as a master regulator of spatial genome 
organization. It was also shown that CTCF co-localizes 
extensively with cohesin during interphase by directly 
binding to its STAG1/2 component [24]. Cohesin is a four 
protein subunit ring complex important in DNA repair, 
chromosome segregation and transcription regulation. 
Within some genomic regions, CTCF-co-localized cohesin 
rather than solely CTCF itself appears to be responsible for 
chromatin contacts. For example, cohesin knockdown was 
shown to abolish long-range cis chromatin contacts 
associated with IFNG locus expression in T helper 1 cells, 
and to reduce gene expression without affecting CTCF 
binding [25]. Similar cohesin-dependent loops and gene 
expression effects have also been observed at other loci. 
These include the beta-globin locus [26] and the 
apolipoprotein gene cluster [27]. Although they are often 
found together on the chromatin, CTCF and cohesin do not 
however exclusively co-localize with each other. Since 
cohesin does not bind DNA directly, this observation points 
to the existence of CTCF-independent cohesin recruitment 
and looping mechanisms. One such mechanism could 
involve tissue-specific transcription factors. Indeed, CTCF-
independent cohesin binding sites frequently co-localize with 
tissue-specific transcription factors [28]. Alternatively, 
transcriptional coactivators such as mediator could recruit 
cohesin [29]. 
  There are many ways by which chromatin interactions 
could be regulated. First, by modifying the DNA itself with 
cytosine methylation and consequently altering protein 
association. An example for this type of regulation is found 
at the imprinted Igf2/H19 locus. On the maternal allele, 
Fig. (1). In vivo genome organization. Individual chromosomes are illustrated by thick green, orange, blue and grey strokes. Respective 
chromosome territories (CT) are highlighted in corresponding colors. Chromatin interactions within (cis) and between (trans) chromosomes 
are represented by orange and red spheres. Transcription factory is shown as a graded circle. MARs: matrix attachment regions. NPC: 
nuclear pore complex. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this 
paper). 
MARs
Nucleus
Cytoplasm
NPC
Nuclear
Matrix
Nuclear
Membrane
CT CT
Transcription 
Factory
cis
transShaping the Genome with Non-Coding RNAs  Current Genomics, 2011, Vol. 12, No. 5    309
expression of the Igf2 gene is inhibited through the 
formation of a repressive loop encompassing the gene. This 
loop requires the recruitment of cohesin through CTCF 
bound at the DMR1 (DNA methylated region 1) and ICR 
(imprinted control region) sequences located upstream of 
Igf2 and H19 respectively [30]. Bound CTCF was also 
shown to recruit the polycomb repressive complex 2 (PRC2) 
at the Igf2 promoter through its Suz12 subunit, thereby 
leading to allele-specific trimethylation of histone H3 lysine 
27 (H3K27me3) and suppression of the maternal Igf2 allele. 
In contrast, binding of CTCF to the ICR is negatively 
regulated by DNA methylation on the paternal allele. This 
lack of binding in turn prevents formation of the repressive 
loop, and enables access of the Igf2 promoter to an enhancer 
located downstream of H19 [31, 32].  
  Chromatin contacts could also be regulated by 
controlling access to DNA sequences with post-translational 
histone modifications (PTMs), the use of histone variants or 
by altering nucleosome positioning. Similarly, post-
translational modification or changes in expression level of 
non-histone chromatin-binding proteins could represent 
important mechanisms to regulate chromatin contacts. 
Additionally, non-coding RNAs (ncRNAs) and their protein 
complexes could regulate the three-dimensional architecture 
of our genome. ncRNAs are a broad class of transcripts 
consisting of structural (rRNAs, tRNAs, snRNAs, snoRNAs, 
etc.), regulatory (miRNAs, piRNAs, etc.), and of sense/anti-
sense transcripts, whose functions remain mostly 
uncharacterized. The latter RNA class includes 
transcriptional “features” (eRNAs, tiRNAs), and a very large 
number of long non-coding RNAs (lncRNAs) ranging in 
length from 200 nt to 100 kb. Although lncRNAs can be 
transcribed nearby known protein-coding genes or from their 
introns, they are often produced intergenically and hence, are 
sometimes referred to as “lincRNAs”. While a number of 
transcripts falling in that category have been studied for 
some time (e.g. Xist, see below), the realization that 
lncRNAs represent a very abundant RNA subclass is 
relatively recent and originates from genome-wide 
transcriptome studies [33-40]. lncRNAs are estimated to be 
at least as abundant as mRNAs, and like mRNAs, their 
expression levels and patterns are often tissue-specific. The 
heterogeneity in sequence, structure and size, along with the 
widely different subcellular localizations of lncRNAs points 
to their involvement in numerous cellular processes [41]. In 
the nucleus, a few lncRNAs were shown to inhibit or 
activate transcription, which is in contrast to other ncRNAs 
thought to represent basic features of transcription.  
  Until recently, DNA sequence and associated proteins 
were thought to mainly dictate spatial genome organization. 
With the abundance and diversity of lncRNAs rivaling that 
of mRNAs, it seems likely that they also play an essential 
role in regulating chromatin organization. In fact, there is 
already evidence for the implication of ncRNA in general 
genome architecture [42], and in maintaining the integrity of 
nuclear bodies [43]. Conversely, chromatin conformation is 
thought to play a role in coordinating gene expression with 
lncRNAs [44]. Below, we report on the nuclear activity of a 
number of best-characterized lncRNAs, and discuss how 
lncRNAs might be instrumental in shaping the three-
dimensional organization of our genome.  
lncRNAs AS INHIBITORS OF TRANSCRIPTION 
  Although most lncRNAs have only recently been 
discovered, a few transcripts belonging to this category have 
already been scrutinized for some time. Amongst these, the 
X-inactive specific transcript (Xist) responsible for 
equalizing gene expression between mammalian males and 
females was first identified in the early 90’s [45, 46]. As 
described below, this lncRNA silences genes in cis by 
coating the chromosome. More recently, a lncRNA termed 
HOTAIR was shown to function in trans. Like the Xist 
transcript, HOTAIR associates with the polycomb repressive 
complex 2 (PRC2) and is thought to repress transcription by 
increasing H3K27me3 levels at specific genes. How these 
transcripts bind and help target polycomb complexes 
specifically to specific regions however is unknown. 
lncRNAs are also important for gene imprinting. For 
example, the Air lncRNA was shown to silence 3 genes in 
cis on the paternal allele at the Kcnq-1 imprinted region. 
Like Xist, the Air transcript coats adjacent chromatin, but 
instead recruits the G9a histone 3 lysine 9 methyltransferase 
(H3K9me3) to repress transcription. Interestingly, other 
lncRNAs such as Kcnq1ot1 silence by binding both PRC2 
and G9a to increase the levels of H3K9me3 and H3K27me3. 
Although repression by PRC2 binding and elevated 
H3K27me3 is thus far the most common mode of inhibition 
(see also ANRIL below), we can expect that many types of 
mechanisms will mediate lncRNA activity in cis and trans
(Fig. (2)). In fact, alternative mechanisms have already been 
identified. For example, the p53-inducible lincp21 ncRNA 
was shown to bind hnRNP-K and inhibit gene expression 
genome-wide following p53 induction. We report below on 
the function and mechanism of some of these inhibitory 
lncRNAs.  
Tsix Repression of Xist 
  In mammals, flies and worms, females differ from males 
by having two X chromosomes rather than one. The 
abundance of X-linked gene products must therefore be 
equalized between sexes in the somatic cells of these 
organisms. In mammals, gene dosage compensation is 
achieved by inactivating one X chromosome in females 
through a process called X chromosome inactivation (XCI). 
XCI requires the Xist lncRNA expressed in cis, which coats 
one female X chromosome and inactivates it by recruiting 
polycomb proteins (reviewed in [47]). Xist is expressed from 
a region on the X chromosome called X inactivation center 
(Xic) where its transcription is controlled by multiple 
lncRNAs. Indeed, the Xic encodes at least 6 other lncRNAs, 
2 of which are known to antagonistically regulate Xist 
expression. On the one hand, the Tsix lncRNA transcribed 
antisense to Xist is known to repress Xist expression on the 
active X (Xa). Conversely, the Jpx lncRNA activates Xist on 
the inactive X (Xi). Tsix represses Xist transcription via 
multiple mechanisms that include recruiting DNA 
methyltransferase activity and the RNA interference 
machinery locally. Tsix is also thought to change the 
epigenetic chromatin state of Xist, thereby preventing Xist 
and RepA (a short transcript corresponding to the 5’end of 310 Current Genomics, 2011, Vol. 12, No. 5 Wang et al.
Xist) from recruiting PRC2 (reviewed in [47]). Interestingly, 
the Tsix gene itself is positively regulated on Xa by another 
Xic-encoded lncRNAs called Xite. How Jpx regulates Xist
will be described below in the next section. Together, XCI 
studies reveal that lncRNAs can regulate the transcription of 
other ncRNAs in addition to protein-coding genes. lncRNAs 
may therefore form very complex regulatory networks that 
control transcription genome-wide. 
HOTAIR 
  In 2007, Chang and colleagues reported the first 
comprehensive analysis of the transcriptional landscapes of 
the four human HOX clusters in 11 different fibroblast cell 
types [48]. In this study, 231 Hox ncRNAs were identified at 
5-bp resolution on custom tilling arrays. Like HOX genes, 
these ncRNAs displayed differential expression along 
developmental axes and marked chromosomal domains with 
different histone methylation patterns and RNA pol II 
accessibility. The HOX clusters encode highly conserved 
eukaryotic transcription factors with pivotal roles in body 
patterning during development. HOX genes were originally 
identified in Drosophila melanogaster and their mammalian 
counterparts are known to have similar developmental 
functions. For example, studies in mouse models 
demonstrated that dysregulated HOX gene expression in 
early development could lead to severe limb and skeletal 
malformations [49-51]. HOX gene expression must also be 
controlled in adult tissues as overexpression of some HOX
genes was found to be a hallmark of certain cancers such as 
leukemia [52, 53]. Although HOX regulation is clearly 
essential during development and for human health, how 
these genes are controlled remains poorly understood to this 
day.  HOX clusters are regulated epigenetically and in 
pluripotent cells rest in so-called bi-valent domains where 
activating H3K4me3 and repressive H3K27me3 histone 
marks co-exist [54, 55]. The study led by Chang and 
colleagues uncovered not only a promising new level of 
HOX regulation, but also showed for the first time that 
lncRNAs can regulate genes in trans. Indeed, a lncRNA 
transcribed at a boundary between active and repressive 
chromatin states in the HOXC cluster was found to repress 
the expression of 5’ end HOXD genes located on another 
chromosome. This RNA is transcribed in an anti-sense 
manner to the HOXC genes and was named HOTAIR for 
“HOX Antisense Intergenic RNA”. HOTAIR is a 2,158 nt 
long spliced and polyadenylated RNA that binds PRC2 and 
silences genes by increasing H3K27me3 levels at specific 
sites [48, 56]. While the 5’ end of HOTAIR was shown to 
bind PRC2 directly through its Suz12 subunit, its 3’ end was 
also shown to bind the LSD1/CoREST/REST H3K4 
demethylase complex. Thus, HOTAIR is thought to provide 
a scaffold for enzyme complexes that increase H3K27me3 
(PRC2) and decrease H3K4me3 levels (LSD1/coREST/ 
REST) to silence gene expression [56].  
  In addition to the HOX genes themselves, which are 
involved in certain types of leukemia, Hox ncRNAs were 
also shown to be dysregulated in breast cancer [57]. 
Amongst these, high HOTAIR expression was found to 
correlate well with increased metastasis and lower patient 
life expectancy. Conversely, loss of HOTAIR expression 
reduced cancer invasiveness suggesting that lncRNAs, 
particularly HOTAIR, might significantly alter the 
epigenome of cancer cells. The association of lncRNAs with 
polycomb complexes sparks numerous questions: How can 
so many different lncRNA sequences bind directly to PRC2? 
How do these transcripts help target protein complexes to 
specific genes? Does the actual lncRNA sequence actively 
participate in targeting the silencing complexes to given 
genes? Might the local accumulation of lncRNAs around 
their transcription sites be sufficient to recruit histone-
modifying enzymes and alter chromatin states?  
Fig. (2). lncRNAs as inhibitors of transcription. lncRNAs expressed from anywhere in the genome can be packaged with transcript-specific 
proteins into functional lncRNPs (long non-coding ribonucleoproteins). The X, Y and Z ovals represent putative transcript-specific proteins 
associated with lncRNAs. lncRNPs could act locally or distally in cis, or in trans. Protein-coding genes are represented by orange, blue and 
green boxes. ncRNA gene is illustrated in grey. Transcription start sites (TSSs) are indicated by bent arrows, with thick arrows showing 
greater transcription activity. TSS of inhibited genes are indicated by thin bent arrows marked with an “X”. (For interpretation of the 
references to color in this figure legend, the reader is referred to the web version of this paper). 
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Local INK4/ARF Locus Control by the ANRIL Non-
Coding Transcript 
 The  human  INK4/ARF locus encodes three tumor 
suppressor genes named p14
ARF, p15
INK4B, and p16
INK4A that 
are often altered in cancers [58]. In normal tissues, these 
genes are epigenetically repressed by PRC2-mediated 
deposition of H3K27me3, and are activated upon cellular 
stress to halt proliferation by inhibiting CDK4, CDK6 and 
MDM2. In 2007, a lncRNA transcribed anti-sense to the 
three tumor suppressor genes was identified along the 
INK4/ARF locus in human testes [59]. The mature 3,834-nt 
transcript was named ANRIL for “Antisense Non-coding 
RNA in the INK4 Locus” and was derived from a 126 kb 
gene composed of 19 exons. In addition to full-length 
ANRIL, a shorter 2,659-nt form was also found in the same 
tissue, and 8 additional splice variants were later identified in 
several cell lines [60]. Although the roles of individual forms 
are unknown, full-length ANRIL was shown to repress 
p15
INK4B expression [61]. Indeed, ANRIL knockdown in 
actively growing cells significantly increased expression of 
p15
INK4B. Similarly, induction of p15
INK4B and p16
INK4A by
oncogenic Ras was found to repress ANRIL expression. It 
was known that the three genes were silenced by PRC2 
under normal cellular condition, and ANRIL knockdown 
significantly reduced PRC2 occupancy and H3K27me3 at 
the  INK4/ARF locus. ANRIL was also found to co-
immunoprecipitate with Suz12 and CBX7, which are 
components of PRC2 and the polycomb repressive complex 
1 (PRC1), respectively [61, 62]. Like PRC2, PRC1 is a 
multisubunit  protein complex and can bind H3K27me3 
through its CBX components [63]. PRC1 is also responsible 
for the ubiquitination of H2AK119 known to inhibit RNA 
pol II transcription elongation [64-66]. Thus, the lncRNA 
ANRIL silences the p15
INK4B gene by recruiting both 
polycomb repressive complexes to halt RNA pol II 
transcription elongation.  
  Another anti-sense transcript named p15-antisense 
(p15AS) was identified at the INK4/ARF locus in 2008 [67]. 
Unlike ANRIL, this RNA measures 34.8 kb in length and 
overlaps only the p15
INK4B gene. Consistent with the frequent 
epigenetic silencing of p15
INK4B in leukemia patient samples, 
higher p15AS levels were often found in acute lymphoblastic 
(ALL) and myeloid leukemias (AML). Thus, it was 
suggested that p15AS could facilitate cancer progression by 
silencing the p15
INK4B tumor suppressor gene. Surprisingly, 
p15AS overexpression increased the repressive H3K9me2 
mark rather than H3K27me3, and decreased the levels of 
activating H3K4me2 near the TSS of the endogenous and 
exogenous p15
INK4B gene. Similar histone modifications were 
also found at the p15
INK4B promoter in cells where the gene is 
silent and no DNA methylation changes were observed. 
These results indicate that p15AS is capable of regulating its 
parental gene in cis and in trans through the formation of a 
type of heterochromatin. Although the silencing mechanism 
has not yet been identified, p15AS appears to trigger 
silencing but not maintain it since removal of the transcript 
did not reverse its effects. 
Gene Imprinting by Air and Kcnq1ot1 
  RNA transcripts important for gene imprinting were 
amongst the first lncRNAs identified in human and mouse. 
Gene imprinting is an epigenetic process that selectively 
represses one or more genes from a parental allele. This 
process was originally thought to result mainly from 
differential DNA methylation at CpG islands [68], but there 
is now overwhelming evidence that histone-modifying 
complexes and lncRNAs also play a significant role in this 
process. The Air and Kcnq1ot1 transcripts are two well-
studied lncRNAs involved in gene imprinting [69, 70]. 
Interestingly, these transcripts differ from Xist, HOTAIR 
and ANRIL by their much larger sizes and absence of 
splicing [70, 71]. The Air transcript (antisense Igf2r RNA) is 
a 107,796-nt long antisense RNA transcribed from the 
second intron of the Igf2r gene to the 3’ end of the Mas gene 
[72]. Air is expressed only from the paternal allele where it 
silences the overlapping Igf2r gene and two other genes 
(Slc22a2 and Slc22a3) downstream of Igf2r [73]. The three 
genes are not consecutive and span approximately 300 kb 
indicating that Air acts specifically in cis. Although it is not 
spliced, Air is transcribed by RNA pol II and thus bears a 5' 
m(7)GpppN cap structure [74]. The full-length RNA 
transcript appears to be required for imprinting since deletion 
of its promoter or gene truncation prevented paternal 
silencing of the three genes [70]. Similarly to Xist, the Air 
lncRNA was found to coat its target genes but instead 
recruits the G9a histone methyltransferase rather than the 
subunits of PRC2 [75]. G9a is a SET domain-containing 
histone methyltransferase similar to polycomb Ezh2 but 
preferentially methylates H3 on lysine 9 (H3K9me3) [76-
78]. Truncation substantially decreased Air lncRNA 
concentration around target genes, reduced G9a recruitment 
at the Igf2r locus, and failed to inhibit the Igf2r, Slc22a2 and 
Slc22a3 genes [75]. 
  The kcnq1ot1 transcript is another well-studied lncRNA 
involved in imprinting [79, 80]. Kcnq1ot1 (also called lit1 
for “long QT intronic transcript 1”) is an antisense transcript 
that shares many common attributes with Air. First, it is a 91 
kb RNA transcribed by RNA pol II, is capped, 
polyadenylated, but not spliced [71]. The transcript is 
expressed from an unmethylated promoter on the paternal 
allele of the kcnq1 (potassium voltage-gated channel, KQT-
like subfamily, member 1) gene and stays in the nucleus to 
silence protein coding genes in cis within the region [79, 81, 
82]. In contrast to Air, which represses three genes at the 
Igf2r locus, Kcnq1ot1 can silence up to 10 genes in the 
Kcnq1 cluster. Surprisingly, Kcnq1ot1 interacts with both 
G9a and the Ezh2 and Suz12 components of the PRC2 
complex, and silences the surrounding genes by spreading 
H3K9me3 and H3K27me3 marks [71, 83]. A silencing 
domain was also identified at the 5’ end of the Kcnq1ot1 and 
further analysis revealed that Kcnq1ot1 silences gene 
expression not only by recruiting HMTs to remodel 
chromatin structure, but also by re-localizing its target genes 
near heterochromatin at the perinucleolar region [84]. 
LincRNA-p21 
 The  p53 tumor suppressor gene encodes a key 
transcription factor, which is mutated in over 50% of human 
cancers. p53 is induced by many types of cellular stresses 
and exerts its tumor suppressor properties primarily through 
its ability to act as a sequence-specific transcription factor 
[85-87]. Many genes are upregulated or downregulated 312 Current Genomics, 2011, Vol. 12, No. 5 Wang et al.
during the p53 transcriptional response. While p53-mediated 
gene activation is relatively well understood, how this 
transcription factor could lead to gene repression was 
unknown until recently. As lncRNAs had been shown to 
silence genes by recruiting chromatin-modifying complexes, 
it seemed possible that p53 might repress genes by activating 
lncRNAs. In 2010, Rinn and colleagues used high-resolution 
tiling arrays featuring predicted lncRNAs to probe the 
ncRNA transcriptome of p53-induced cells [88]. The custom 
tiling arrays included 400 genomic regions outside known 
protein-coding genes that were selected based on the 
presence of active H3K4me3 and H3K36me3 histone marks 
[89, 90]. Over 30 lncRNAs were induced by p53 in two 
different cellular systems indicating that like protein-coding 
genes, numerous lncRNAs are also temporally regulated 
during the p53 transcriptional response. Two lncRNAs 
containing canonical p53 binding sites in their promoters 
were shown to be bona fide p53 transcription targets and one 
was retained for further analysis. The lncRNA named 
lincRNA-p21 was interesting because of its curious genomic 
position approximately 15 kb upstream of the p21 cell cycle 
regulator, which is a well-known p53 target gene. lincRNA-
p21 is a 3.1 kb spliced and polyadenylated RNA transcribed 
from the opposite strand to p21, and is conserved in human 
and mouse. Individual knockdown of p53 and lincRNA-p21 
revealed a strong overlap in derepressed genes indicating 
that lincRNA-p21 participates in p53-mediated gene 
repression. Common derepressed genes were enriched in 
those involved in cell cycle arrest and apoptosis although 
further analysis indicated that lincRNA-p21 increases 
apoptosis without any significant effects on the cell cycle. 
Intriguingly, lincRNA-p21 was found to interact with 
hnRNP-K through a 780 nt region at its 5’end. Although 
deletion of this region abolished the ability of lincRNA-p21 
to induce apoptosis, the region alone was not sufficient to 
trigger it. Furthermore hnRNP-K knockdown also showed a 
strong overlap in derepressed genes with lincRNA-p21 and 
p53, indicating that hnRNP-K is involved in the repression 
of many p53 downregulated genes likely through lincRNA-
p21. Accordingly, the authors found that hnRNP-K is at the 
promoter of many p53-repressed genes by chromatin 
immunoprecipitation. How hnRNP-K can repress 
transcription however is unknown and it will be interesting 
to see how it is specifically recruited at gene promoters.  
lncRNAs AS ACTIVATORS OF TRANSCRIPTION  
  Transcription activation by lncRNAs is a much more 
recent discovery than inhibition. Antisense ncRNAs 
transcribed intergenically from the HOXA cluster were 
amongst the first transcripts found to induce protein-coding 
genes. Like HOTAIR, HOXA-encoded lncRNAs are tissue-
specific, transcribed by RNA pol II, spliced and 
polyadenylated. However, these transcripts appear to mainly 
induce the expression of neighboring genes in cis. In fact, no 
lncRNA has yet been shown to induce protein-coding genes 
in  trans. Activating lncRNAs have since been reported 
genome-wide in a number of cell types. As for HOXA
lncRNAs, they are often tissue-specific and transcribed by 
RNA pol II. However, some of these transcripts were found 
to induce distal genes within at least 300 kb away without 
necessarily affecting the ones adjacent to them. This type of 
specific long-range regulation suggests that three-
dimensional chromatin architecture might be important for 
their activity. Activation by lncRNAs does not seem to be 
restricted to protein-coding genes since XCI was recently 
shown to require this type of mechanism. There will likely 
be many mechanisms by which lncRNAs can activate 
transcription (Fig. (3)) although most are currently unknown. 
Below are examples of lncRNAs thought to play a role in cis
transcription activation.  
Hox-Encoded ncRNAs, HOTAIRM1, and HOTTIP 
  An interesting aspect to HOX cluster regulation is 
reflected in the developmental expression pattern of their 
genes. During development, HOX genes are expressed in a 
spatio-temporal manner that is colinear with their positions 
along chromosomes [91, 92]. For example, genes located at 
the 3’ end of the clusters are usually expressed more 
anteriorly and earlier in the embryo than those at the 5’ end. 
Although genetic evidence suggests a role for three-
dimensional chromatin organization in colinearity, how this 
type of HOX regulation occurs is unclear [93]. In early 2007, 
Orlando and colleagues used the well-described NT2/D1 cell 
differentiation system to investigate the role of intergenic 
HOXA ncRNAs in regulating cis gene expression [94]. 
NT2/D1 are human pluripotent embryonic carcinoma cells 
that can be terminally differentiated into neural-like cell 
lineages upon treatment with retinoic acid (RA). RA 
treatment also recapitulates the 3’-5’ induction pattern of the 
HOXA1 to A5 3’ end genes in developing axial systems. The 
study showed that RA induces antisense HOXA ncRNAs in a 
manner that follows the collinear activation pattern of the 
protein-coding genes. Importantly, ncRNA induction was 
also accompanied by local changes in histone modifications 
and loss of repressive PcG complexes. It was proposed that 
antisense ncRNA transcription is fundamentally important to 
open and maintain the active state of HOX clusters during 
RA induction. In this model, the process of transcription 
itself rather than transcripts per se could represent an anti-
silencing mechanism. The authors suggested that ncRNA 
genes might contain regulative epigenetic DNA elements 
and that transcription through them may counteract 
repression and maintain RA activation. Although we still do 
not know which elements could be at these sites, an 
attractive possibility is that transcription displaces 
chromatin-looping factors and disrupts repressive three-
dimensional conformations. We previously reported the 
presence of long-range chromatin loops in the 
transcriptionally silent HOXA cluster in THP-1 and NT2/D1 
cells [95, 96]. We found that RA treatment abolished these 
loops in NT2/D1 cells and suggested that the insulator-
binding protein CTCF might be an important looping factor 
[96]. It will be interesting to determine the role of CTCF in 
regulating HOXA gene expression.  
 HOXA ncRNA expression is not restricted to the 
induction of pluripotent cells with RA. HOX cluster 
transcriptome analysis in human fibroblasts actually 
identified hundreds of ncRNAs throughout the four clusters 
[48]. By using cells corresponding to various anatomical 
sites along developmental axes, this study revealed that 
ncRNA transcription is often tissue-specific and might 
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specific antisense lncRNA transcribed between HOXA1 and 
A2 was more recently identified in the myeloid cell lineage 
[97]. Because of its myeloid-specific expression, the 
transcript was termed HOTAIRM1 for “HOX Antisense 
Intergenic RNA Myeloid 1”. HOTAIRM1 is 500 nt in 
length, transcribed by RNA pol II, spliced and 
polyadenylated. It is the most highly expressed HOXA
lncRNA product following RA differentiation of NB4 cells 
into granulocytes and is highly expressed in leukocytes 
during normal human hematopoiesis. HOTAIRM1 
knockdown in NB4 cells prevented RA induction of HOXA1
and  A4, and attenuated the induction of the CD11b and 
CD18 granulocyte maturation genes. These results therefore 
suggest that transcription activation by HOTAIRM1 may not 
be restricted to its immediate HOXA neighboring genes, and 
it will be intriguing to determine its role in hematopoiesis 
and leukemogenesis.  
  An article recently published by the Chang group also 
reports a lncRNA at the distal 5’ end of the HOXA cluster 
termed HOTTIP for “HOXA Transcript at the distal TIP” 
[44]. This 3,764-nt ncRNA is spliced, polyadenylated, and 
preferentially expressed at distal anatomical sites where 5’ 
end  HOX genes are usually expressed. For example, 
HOTTIP was detected in human foreskin fibroblasts but not 
in lung. It was also expressed in mouse limbs at E13.5 and in 
chick limb buds. HOTTIP was shown to positively regulate 
the expression of 5’ HOXA genes in human distal fibroblasts 
and developing chick limbs. Indeed, knockdown of HOTTIP 
in foreskin fibroblasts resulted in lower 5’ HOXA gene 
expression and reduced H3K4me3 at promoters, but did not 
affect the levels of H3K27me3 along the cluster. Consistent 
with the role of 5’ end HOXA genes in limb development, 
HOTTIP shRNA injection in chicken embryos interfered 
with the formation of distal bony elements of the wing. 
These results show that HOTTIP might promote 5’ end 
HOXA transcription epigenetically by increasing the levels 
of activating histone marks. The mixed lineage leukemia 
proteins MLL1 and MLL2 are primarily responsible for 
trimethylation of H3K4 at the HOX clusters and HOTTIP 
was found to interact directly with the WDR5 component of 
the MLL modifying complex. HOTTIP knockdown reduced 
MLL-1 and WDR5 binding at the 5’ end HOX gene 
promoters suggesting that the lncRNA is required to recruit 
the methyltransferase complex to the chromatin. However, 
ectopic expression of HOTTIP in non-expressing cells did 
not activate the transcription of 5’ end HOXA genes. 
Similarly, HOTTIP overexpression in foreskin fibroblasts 
did not further enhance HOXA gene expression or rescue the 
effects of depleting endogenous nascent HOTTIP RNA. 
These results were explained with the suggestion that 
HOTTIP might only regulate genes when expressed 
immediately in cis of its targets and by hijacking pre-existing 
higher-order chromosomal structures that group regulated 
genes in close physical proximity to nascent HOTTIP RNA. 
Accordingly, 5C analysis of the HOXA cluster in fibroblasts 
indicated that HOTTIP expression correlates with enhanced 
chromatin interactions at the cluster 5’ end between 
HOXA13 and HOXA7. Frequent chromatin contacts 
corresponded to higher H3K4me3 levels and low 
H3K27me3 marks, and HOTTIP knockdown had no effect 
on three-dimensional chromatin organization. Thus, 
HOTTIP might represent an example whereby spatial 
chromatin organization is required to regulate gene 
expression by lncRNAs in cis. We have previously shown 
that the transcriptionally silent HOX clusters are extensively 
folded in different cell lines [95, 96]. Our findings along 
with the HOXA structural data summarized above and the 
exquisite richness of HOX clusters in lncRNAs suggest that 
the clusters might be regulated in a cell type-specific manner 
by different mechanisms involving both chromatin 
architecture and lncRNAs.  
Fig. (3). lncRNAs as activators of transcription. (top) The process of lncRNA transcription and not the transcript itself could be responsible 
for cis activation of neighboring genes by maintaining or initiating the chromatin structure in an active state. (bottom) lncRNAs can be 
packaged with transcript-specific proteins into lncRNPs to selectively activate gene expression in cis. Protein-coding genes are represented 
by orange and green boxes. lncRNA genes are illustrated in grey. Transcription start sites (TSSs) are indicated by bent arrows. Thick red bent 
arrows indicate active protein coding genes and thick black arrows active lncRNA genes. (For interpretation of the references to color in this 
figure legend, the reader is referred to the web version of this paper). 
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Activating lncRNAs (ncRNA-a) 
  In 2010, Orom and colleagues used GENCODE 
annotation data to search for uncharacterized human 
lncRNAs [98, 99]. By focusing on intergenic transcripts 
classified to have no coding potential by the HAVANA 
group (Human and Vertebrate Analysis and Annotation; 
Sanger Institute), they identified 3019 putative long non-
coding RNAs. These transcripts displayed chromatin 
signatures similar to protein-coding genes with high 
H3K4me3 at their 5’ ends and H3K36me3 along their bodies 
when transcriptionally active. In contrast to mRNAs 
however, the identified lncRNAs were shorter with an 
average transcript size of 800 nt. Their genes were also less 
complex than protein-coding genes with nearly 50% of them 
featuring a single intron. lncRNA expression analysis on 
custom arrays indicated that approximately 20% were 
ubiquitously expressed while over 33% displayed differential 
expression patterns across cell lines. Furthermore, it was 
found that the expression of many lncRNAs was regulated 
during cellular differentiation. Interestingly, functional 
knockdown analysis revealed an enhancer-like function for a 
set of lncRNAs. Indeed it was found that depletion of 
lncRNAs at multiple loci could result in a specific decrease 
in the expression of protein-coding genes in cis.
Transcription activation was shown to be RNA-dependent, 
as evidenced by heterologous transcription assays. 
Importantly, some of these “ncRNA-a” were found to 
activate the transcription of critical regulators of 
development and cellular differentiation. For example, the 
Snai1 and Snai2 master regulators of hematopoiesis were 
downregulated following depletion of neighboring lncRNAs. 
Specifically, ncRNA-a7 RNAi knockdown was accompanied 
with less Snai1 expression and recapitulated the effects of 
Snai1 depletion itself. Interestingly, ncRNA-a7 depletion 
also led to a decrease in the expression of the Aurora-kinase 
A gene located 6 Mb away from the lncRNA gene. In fact, 
transcriptional effects were not restricted to immediate 
neighboring genes for many ncRNA-a, and could extend at 
least 300 kb away from the transcription units without 
necessarily affecting all genes in between. Thus, like HOX-
encoded lncRNAs, these results suggest that spatial 
chromatin organization might play an important role in the 
specific activation of target genes.  
Jpx Activation of Xist 
  In addition to activating the transcription of protein-
coding genes, lncRNAs can also induce the expression of 
other lncRNAs. This type of regulation was found to be 
essential for XCI where Xist expression is repressed by Tsix 
on the Xa but induced by Jpx on Xi. Jpx is one of the 6 
ncRNAs encoded at the Xic that was recently shown to be 
required for XCI [100]. Specifically, Jpx was found to derive 
mainly from the Xi and its expression to correlate with Xist 
transcription. Importantly, deleting Jpx in mouse blocked 
XCI and was female lethal. This phenotype was rescued by 
truncating Tsix suggesting that antagonistic lncRNA 
switches control XCI. Although it can work in trans, Jpx was 
found to have a mild preference for cis activation. 
Interestingly, previous 3C analysis of the Xic revealed 
higher-order chromatin contacts between the Jpx gene 5’ end 
and the Xist gene [101]. This result suggests that similarly to 
HOTTIP, three-dimensional chromatin organization might 
participate in preferentially targeting the Jpx lncRNA to its 
cis-located Xist allele. This study also reinforces an 
important principle in lncRNA function: that lncRNAs can 
regulate the expression of other lncRNAs. As such, it seems 
very likely that this type of regulatory network will play a 
role in the regulation of protein-coding genes. 
ncRNAs AS BASIC TRANSCRIPTIONAL FEATURES  
  Ascribing a function to long ncRNAs that are capped, 
spliced, polyadenylated and tissue-specific is intuitively 
easier to accept than to do the same for low abundance, 
short, and apparently unprocessed transcripts. In the past, 
short ncRNAs were often viewed as likely degradation 
products or as transcriptional “noise”, and were routinely 
discarded from datasets. Several groups have now taken a 
closer look at these RNAs and show that their non-random 
distribution is incompatible with aberrant transcription or 
with the truncated fragments of highly expressed genes. 
Short ncRNAs tend to be derived specifically from enhancer 
and promoter regions, and their expression levels, although 
very low, usually rises with increasing transcription (Fig. 
(4)). Regardless of whether these transcripts are simple 
manifestations of transcription activity or have actual 
regulatory functions, we can certainly learn much about 
transcription by taking a closer look at them.  
Enhancer-Associated RNAs (eRNAs) 
  Enhancer sequences are scattered throughout mammalian 
genomes and are often activated in a tissue-specific manner. 
Enhancers can be identified by their association with the 
p300/CBP transcriptional co-activator, by the presence of 
histone 3 lysine 4 monomethylation marks (H3K4me1), and 
by their separate position to known transcription start sites 
(TSSs) [102]. Greenberg and colleagues recently used these 
enhancer traits to identify thousands of regulated enhancers 
during cortical neuron stimulation [103]. The study reports 
that most regulated p300/CBP binding sites are at least 1 kb 
away from known TSSs. Thus, transcription-dependent 
p300/CBP binding mainly occurs at enhancers rather than 
promoters in this system. Stimulation did not significantly 
change the histone modification landscape suggesting that 
chromatin is likely maintained permissive for induction in 
these cells. However, many transcription factors (TFs) were 
found to co-localize at enhancers, thereby raising the 
possibility that TFs might regulate enhancer function partly 
by recruiting p300/CBP. Strikingly, roughly 25% of 
enhancer-bound p300/CBP was found to bind RNA pol II in 
a transcription-dependent manner. Furthermore, short RNAs 
(< 2kb) transcribed bi-directionally from the center of 
enhancer domains could be detected from these sites. These 
transcripts were termed eRNAs for “enhancer RNAs” and 
appear to be non-polyadenylated. An interesting feature 
about eRNA transcription is that their levels correlate with 
the activity of nearby protein coding genes during neuronal 
stimulation. As such, enhancers may not strictly be 
recruitment sites of TFs, p300/CBP and RNA pol II but also 
sites of transcription. Changes in eRNA expression at 
actively transcribed enhancers were strongly correlated with 
regulated mRNA levels at nearby genes, and suggested that 
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with promoters. This hypothesis was confirmed by the 
absence of eRNA production from the active Arc gene 
enhancer in cells lacking the Arc promoter and most of the 
gene. Whether the transcriptional process itself or actual 
eRNA transcripts play a role in enhancer activation by 
modifying the chromatin state remains unknown. 
Nonetheless, this study not only clearly demonstrates that 
enhancers can be transcribed but also indicates that long-
range looping rather than transcription-dependent RNA pol 
II tracking is a likely more widespread mechanism by which 
distal enhancers regulate target genes.  
Transcription Initiation RNAs (tiRNAs) 
Short ncRNAs mapping nearby gene promoters have 
been reported in several species over the past five years 
[104-106]. These studies together led to the hypothesis that 
genomes might encode multifunctional sequences that 
sometimes function as regulatory DNA elements and 
sometimes generate multiple independently regulated 
transcripts [107]. In 2009, the Mattick group examined small 
RNA deep-sequencing libraries from human, chicken and 
Drosophila to further characterize TSS-associated transcripts 
[108]. This study uncovered a new class of short ncRNAs 
mapping within 60 upstream to 120 bp downstream of 
annotated TSSs that were named tiRNAs for “transcription 
initiation RNAs”. The 5’ ends of tiRNAs peaked at 10 to 30 
nts downstream from the TSS of their parent genes 
indicating that they are not simply RNA pol II runoff or 
truncated 5’ capped ends. They were found in all 3 species, 
and although slightly different in lengths, most were shorter 
than 22 nt with over a quarter measuring 18 nucleotides. 
tiRNAs were usually transcribed from the same strand as 
their corresponding TSS and were preferentially derived 
from GC-rich promoters. Consistently, promoters with 
tiRNAs were enriched in RNA pol II and binding of the Sp1 
transcription factor. Curiously, tiRNAs were more frequently 
associated with highly expressed genes but their abundance 
did not directly correlate with gene expression levels. 
Furthermore, tiRNA synthesis was independent from the 
RNAi processing machinery indicating that they are likely 
derived directly from the RNA pol II activity at promoters. 
At least in Drosophila, tiRNA expression was only weakly 
associated with stalled transcripts produced at poised 
promoters. The authors therefore suggested that tiRNAs 
might represent products of RNA pol II backtracking, a 
process known to require the elongation and transcription 
cleavage factor TFIIS [109]. In a more recent paper, the 
same group reported a 40-fold nuclear enrichment of tiRNAs 
and demonstrated their association with transcription 
initiation marks [110]. Interestingly, tiRNAs were found to 
possess a 3’-guanine nucleotide bias in all 3 species, which 
further supports their non-random origin. tiRNA production 
is therefore a basic transcriptional feature in metazoans that 
may function in regulating chromatin modifications to fine-
tune transcription.  
lncRNAs AS REGULATORS OF SPATIAL GENOME 
ORGANIZATION 
  The histone-modifying activity of lncRNPs points to their 
pivotal role in regulating spatial genome organization. 
Although lncRNAs have thus far been predominantly 
associated with repressive complexes that methylate H3K27 
or H3K9, it seems safe to predict that many more enzymatic 
activities will likely associate with these transcripts. Post-
translational histone modifications may affect three-
dimensional chromatin structure by altering the binding of 
nucleosomes to the DNA, the contacts between 
nucleosomes, or by changing the recruitment of non-histone 
Fig. (4). ncRNAs as basic transcriptional features. (A) Bi-directional short ncRNAs produced from the center of enhancer sequences can be 
detected in cortical neurons. These “enhancer RNAs” (eRNAs) are only found near active genes and require RNA pol II. eRNA production 
would presumably require contact between the enhancer and transcribed gene. (B) Short (18 nt) transcription initiation RNAs (tiRNAs) can 
be detected at active genes. tiRNAs preferentially map around TSSs of highly transcribed genes and sites of RNA pol II binding. Protein-
coding genes are represented by orange or blue boxes. Active transcription start sites (TSSs) are indicated thick red bent arrows. Enhancer 
sequence (E) is shown as a yellow box and promoter (P) as a green rectangle. (For interpretation of the references to color in this figure 
legend, the reader is referred to the web version of this paper). 
A
B
+++
E P
Chr. A
eRNAs
Chr. B
+++
tiRNAs
-60 to +120316 Current Genomics, 2011, Vol. 12, No. 5 Wang et al.
proteins. For example, changes in histone charge introduced 
by acetylation or phosphorylation might significantly affect 
in vivo nucleosome interactions and chromatin compaction 
levels. Many protein complexes recognizing specific PTMs 
have now been identified and usually include enzymatic 
activities that further modify chromatin. Enzymatic activities 
include HDACs, HATs, HDMTs, HMTs, ubiquitin ligases, 
and chromatin remodelers. How histone PTMs can tether 
histone-modifying complexes has been extensively described 
elsewhere ([5] and references therein).  
  At least in chicken and Drosophila, there is also evidence 
that ncRNAs themselves contribute to higher-order genome 
organization [42]. The Azorin group showed that polyA- 
RNA associates with chromatin where it represents 
approximately 2 to 5% of total nucleic acids. When they 
treated chromatin with RNase A, fragments sedimented less 
rapidly on sucrose gradients and were more sensitive to 
micrococcal nuclease. These structural changes were not 
correlated with any significant alteration in histone 
composition and were observed at euchromatin and 
heterochromatin. It was suggested that RNA might stabilize 
the binding of non-histone proteins to chromatin as was 
previously shown for HP1 at pericentric heterochromatin 
[111, 112]. A similar type of mechanism was also recently 
reported at repressed PcG target genes where short 
transcripts produced around TSSs can bind PRC2 complexes 
and might strengthen their association with the genes [113].  
  Specific ncRNAs may also nucleate the formation of 
functional nuclear subdomains or be required to maintain 
their integrity. The ncRNA NEAT1 (Nuclear Enriched 
Abundant Transcripts 1) is a very good example for this type 
of activity [114]. NEAT1 is a ubiquitously expressed nuclear 
lncRNA of 3.7 kb that is unspliced but polyadenylated [115]. 
It is highly expressed and localizes mainly to a type of 
membraneless nuclear body termed “paraspeckle”. The 
function of paraspeckles is not well defined but thought to 
represent nuclear retention sites of adenosine-to-inosine (A-
I) edited transcripts [116]. NEAT1 knockdown was shown to 
disrupt paraspeckles and its overexpression to result in a 
larger number of them [117]. Another lncRNA termed 
NEAT2 for “Nuclear Enriched Abundant Transcript 2” was 
found to preferentially localize to splicing speckles, which is 
another type of nuclear subcompartment enriched in splicing 
factors [115]. NEAT2 is a 8.7 kb unspliced, polyadenylated 
transcript with a similar expression pattern to NEAT1 that 
represent the bulk of polyA+ RNA in speckles. Although 
NEAT2 does not appear to play a structural role in these 
bodies as detected by epifluorescence [117], there is 
evidence suggesting that it may regulate mRNA alternative 
splicing by altering the ratio of phosphorylated and 
unphosphorylated SR splicing factor inside the speckles 
[118].  
  In addition to their involvement in the function of nuclear 
subdomains, ncRNPs could also control higher-order 
chromatin architecture and transcription activity by 
mediating long-range contacts. There are many ways by 
which lncRNAs could affect gene expression through long-
range interactions. For example, lncRNAs might cluster to 
Fig. (5). lncRNAs as regulators of spatial genome organization. (A) A lncRNP produced in cis or in trans could drive the formation of 
activating contacts that bridge enhancers to promoters, or induce the formation of a transcription factory. This example illustrates how a cis
lncRNA could lead to the coordinated activation of gene clusters. (B) Activating long-range looping contacts between enhancers and 
promoters could be disrupted by transcription of a lncRNA. In this example, lncRNA transcription itself rather than the transcript could be 
responsible for transcription inhibition of neighboring genes. This example shows one CTCF protein displaced by transcription and 
disruption of an activating loop. Protein-coding genes are represented by colored boxes. Transcription start sites (TSSs) are indicated by bent 
arrows, with thick red bent arrows indicating active protein coding genes and thick black arrows active lncRNA genes. TSS of inhibited gene 
is indicated by a thin bent arrow marked with an “X”. (For interpretation of the references to color in this figure legend, the reader is referred 
to the web version of this paper). 
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form nuclear organization centers that coordinate gene 
expression. Good candidates for this type of activity are 
PcG-bound lncRNAs since polycomb complexes are known 
to form long-range cis and trans interactions genome-wide 
[119]. In this case, physical lncRNP networks would 
facilitate the coordinated down-regulation of multiple genes. 
Given the increasing complexity of RNA sequences found to 
interact with PRC2, it will be interesting to see which 
lncRNAs may be involved in this type of distal regulation. 
lncRNP-dependent physical networks could also be 
important for the formation of transcription factories (Fig. 
(5A)). Alternatively, lncRNA transcription might enhance or 
inhibit transcription of neighboring genes by displacing 
proteins from the chromatin and altering physical loops (Fig. 
(5B)). In this case, it is the transcription process itself rather 
than the transcripts that would mediate changes in gene 
expression. The lncRNAs genes themselves may also 
regulate chromatin architecture. For instance, lncRNA genes 
might cluster with other genes to promote the formation of 
transcription factories and gene expression. Additionally, 
lncRNA genes could compete with other genes (protein-
coding or otherwise) for the same enhancers or other type of 
regulatory DNA element.  
CONCLUSION 
  The discovery that lncRNAs represent a very large 
portion of our transcriptome has uncovered a new level of 
gene expression regulation. Although we know very little 
about them, their sequence diversity, potential splice 
variants, and cellular distribution suggests an important role 
in many aspects of RNA transcription, processing, and 
metabolism. The tissue-specificity and low conservation of 
lncRNAs amongst higher eukaryotes also points to their 
potential contribution in establishing or maintaining cell 
identity. Because of the overwhelming lncRNA complexity, 
recent studies have mainly focused on the function of 
individual transcripts in the nucleus. These studies clearly 
demonstrate that lncRNAs can regulate genes by various 
epigenetic mechanisms involving chromatin-modifying 
complexes. An interesting possibility is that lncRNAs also 
regulate transcription by altering chromatin architecture. 
Such spatial transcription regulation mechanisms could play 
an important role in human health and disease and it will be 
interesting to see how lncRNA function intersects with 
spatial chromatin architecture.  
ABBREVIATIONS 
3C  =  Chromosome conformation capture 
rRNAs =  Ribosomal  RNAs 
tRNAs =  Transfer  RNAs 
snRNAs  =  Small nuclear RNAs 
snoRNAs =  Small  nucleolar  RNAs 
miRNAs = MicroRNAs 
piRNAs =  Piwi-interacting  RNAs 
eRNAs =  Enhancer  RNAs 
tiRNAs  =  Transcription initiation RNAs 
spliRNAs =  Splice-site  RNAs 
lincRNAs  =  Long intergenic non-coding RNAs 
lncRNPs  =  Long non-coding ribonucleoprotein 
complexes 
Igf2r  =  Insulin-like growth factor II receptor 
HMTs =  Histone  methyl  transferases 
TSSs  =  Transcriptional start sites 
TFs =  Transcription  factors 
RNAi =  RNA  interference 
PTMs =  Post-translational  modifications 
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